BioShin names new chief medical officer and chief commercial officer
8 July 2021 -

China-based BioShin Limited announced on Thursday that it has named Dr Zhihong (Sarah) Lu as its new chief medical officer and Dr Ma (Mary) Li as its new chief commercial officer.

Dr Lu has served as president of Global Development for Shanghai Green Valley. She has also served in various leadership roles at various Multinational and local Chinese companies, including UCB, Solvay GSK and Simcere. She has 24 years of clinical development experience and led the clinical development of over 20 small and large molecules.

Dr Li has over 18 years of experience in the China healthcare market. She has held various senior commercial positions in capacities including sales, marketing, commercial excellence with companies such as GSK, Eli Lilly, Abbvie and MSD. She has experience in commercial strategy and operations, new product launches and patient access.